![](/img/cover-not-exists.png)
759PPhase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer
Yoon, J S, Lee, K-H, Cheon, G J, Bang, Y-J, Oh, D-YVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.142
Date:
October, 2018
File:
PDF, 75 KB
2018